神B
2020-12-10
妖
@美股投资网：
【妖股出现】单日暴涨2941%，震惊华尔街，代号 GLSI
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":395354261,"tweetId":"395354261","gmtCreate":1607593974353,"gmtModify":1703848904495,"author":{"id":3485333325177727,"idStr":"3485333325177727","authorId":3485333325177727,"authorIdStr":"3485333325177727","name":"神B","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>妖</p></body></html>","htmlText":"<html><head></head><body><p>妖</p></body></html>","text":"妖","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/395354261","repostId":395950273,"repostType":1,"repost":{"magic":2,"id":395950273,"tweetId":"395950273","gmtCreate":1607568662692,"gmtModify":1703848750251,"author":{"id":3478213283465426,"idStr":"3478213283465426","authorId":3478213283465426,"authorIdStr":"3478213283465426","name":"美股投资网","avatar":"https://static.tigerbbs.com/a1bfd2cf1aa240d7058795c83d419510","vip":6,"userType":6,"introduction":"美股投资网","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18932,"starInvestorFlag":false},"themes":[{"themeId":"45690586ebfb429d952407377828c6c0","categoryId":"b76d3c59fc044df59779c041b25852a6","name":"今天什么值得买？晒晒你的交易计划！","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":45690586ebfb429d952407377828c6c0}&rnconfig={\"headerBarHidden\": true}","description":"今天你有什么交易计划？什么标的值得关注？在本主题下发帖，分享你的想法吧！","image":"https://static.tigerbbs.com/ce10cf181856307d0983c3bc1075120b"}],"images":[{"img":"https://static.tigerbbs.com/590bcce9c34193a05ef63ba1c7cb8163","width":"688","height":"430"},{"img":"https://static.tigerbbs.com/4e2c44ef247e1bb398b94cf93b54da5a","width":"600","height":"669"}],"coverImages":[{"img":"https://static.tigerbbs.com/590bcce9c34193a05ef63ba1c7cb8163","width":"996","height":"622"},{"img":"https://static.tigerbbs.com/4e2c44ef247e1bb398b94cf93b54da5a","width":"600","height":"669"}],"title":"【妖股出现】单日暴涨2941%，震惊华尔街，代号 GLSI","extraTitle":"","html":"<html><head></head><body><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4e2c44ef247e1bb398b94cf93b54da5a\" tg-width=\"600\" tg-height=\"669\"></p><p> 格林威治生命科学公司(GLSI<strong>)今日股价飙升2,941%，24次熔断</strong>，日内交易者争相买入这家微型市值制药公司的股票。有1700多万股股票换手，是30天平均水平的700多倍。<a target=\"_blank\" href=\"https://laohu8.com/S/GLSI\">$Greenwich Lifesciences Inc(GLSI)$</a> </p><p>格林尼治首席执行长帕特尔(SnehalPatel)持有该公司65%的股份，当日收盘时该公司市值为6.86亿美元。这一切都源于格林威治生命科学公司在圣安东尼奥乳腺癌研讨会(SABCS)上发布<strong>的GP2期IIb临床试验五年数据，显示乳腺癌的复发率为0%</strong></p><p> 格林威治生命科学是一家临床生物制药公司，专注于GP2的研发。GP2是一种免疫疗法，用于预防曾接受过手术的患者的乳腺癌复发。迄今为止，138名接受GP2治疗的患者进行了4次临床试验，GP2治疗耐受性良好，没有观察到与GP2免疫治疗相关的严重不良事件。格林威治生命科学公司正计划开始III期临床试验，使用与IIb期临床试验类似的治疗方案。治疗类似人群的中度至重度(高风险T1,T2-T4)乳腺癌患者。</p><p> 格林尼治首席执行长帕特尔(SnehalPatel)说:“大约80-85%的转移性乳腺癌患者不能存活。通过解决这一未被满足的需求，GP2可能达到一个超过50亿美元的潜在市场。”<a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/DASH\">$DoorDash, Inc.(DASH)$</a> </p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/590bcce9c34193a05ef63ba1c7cb8163\" tg-width=\"688\" tg-height=\"430\"></p></body></html>","htmlText":"<html><head></head><body><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4e2c44ef247e1bb398b94cf93b54da5a\" tg-width=\"600\" tg-height=\"669\"></p><p> 格林威治生命科学公司(GLSI<strong>)今日股价飙升2,941%，24次熔断</strong>，日内交易者争相买入这家微型市值制药公司的股票。有1700多万股股票换手，是30天平均水平的700多倍。<a target=\"_blank\" href=\"https://laohu8.com/S/GLSI\">$Greenwich Lifesciences Inc(GLSI)$</a> </p><p>格林尼治首席执行长帕特尔(SnehalPatel)持有该公司65%的股份，当日收盘时该公司市值为6.86亿美元。这一切都源于格林威治生命科学公司在圣安东尼奥乳腺癌研讨会(SABCS)上发布<strong>的GP2期IIb临床试验五年数据，显示乳腺癌的复发率为0%</strong></p><p> 格林威治生命科学是一家临床生物制药公司，专注于GP2的研发。GP2是一种免疫疗法，用于预防曾接受过手术的患者的乳腺癌复发。迄今为止，138名接受GP2治疗的患者进行了4次临床试验，GP2治疗耐受性良好，没有观察到与GP2免疫治疗相关的严重不良事件。格林威治生命科学公司正计划开始III期临床试验，使用与IIb期临床试验类似的治疗方案。治疗类似人群的中度至重度(高风险T1,T2-T4)乳腺癌患者。</p><p> 格林尼治首席执行长帕特尔(SnehalPatel)说:“大约80-85%的转移性乳腺癌患者不能存活。通过解决这一未被满足的需求，GP2可能达到一个超过50亿美元的潜在市场。”<a target=\"_blank\" href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/DASH\">$DoorDash, Inc.(DASH)$</a> </p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/590bcce9c34193a05ef63ba1c7cb8163\" tg-width=\"688\" tg-height=\"430\"></p></body></html>","text":"格林威治生命科学公司(GLSI)今日股价飙升2,941%，24次熔断，日内交易者争相买入这家微型市值制药公司的股票。有1700多万股股票换手，是30天平均水平的700多倍。$Greenwich Lifesciences Inc(GLSI)$ 格林尼治首席执行长帕特尔(SnehalPatel)持有该公司65%的股份，当日收盘时该公司市值为6.86亿美元。这一切都源于格林威治生命科学公司在圣安东尼奥乳腺癌研讨会(SABCS)上发布的GP2期IIb临床试验五年数据，显示乳腺癌的复发率为0% 格林威治生命科学是一家临床生物制药公司，专注于GP2的研发。GP2是一种免疫疗法，用于预防曾接受过手术的患者的乳腺癌复发。迄今为止，138名接受GP2治疗的患者进行了4次临床试验，GP2治疗耐受性良好，没有观察到与GP2免疫治疗相关的严重不良事件。格林威治生命科学公司正计划开始III期临床试验，使用与IIb期临床试验类似的治疗方案。治疗类似人群的中度至重度(高风险T1,T2-T4)乳腺癌患者。 格林尼治首席执行长帕特尔(SnehalPatel)说:“大约80-85%的转移性乳腺癌患者不能存活。通过解决这一未被满足的需求，GP2可能达到一个超过50亿美元的潜在市场。”$特斯拉(TSLA)$ $DoorDash, Inc.(DASH)$","highlighted":2,"essential":1,"paper":2,"link":"https://laohu8.com/post/395950273","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["TSLA","DASH","GLSI"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":913,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":1327,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/395354261"}
精彩评论